mr antagonist
An antimineralocorticoid, also known as a mineralocorticoid receptor antagonist (MCRA) or aldosterone antagonist, is a diuretic drug which antagonizes the ... ,Two mineralocorticoid receptor antagonists, spironolactone and eplerenone, are currently approved by the FDA. Several non-steroid based ligands are in ... ,Mineralocorticoid receptor (MR) antagonist spironolactone (SPL) is an effective agent for prevention of cardiovascular injury. However, whether and how SPL ... ,Spironolactone and eplerenone are both mineralocorticoid-receptor antagonists. These compounds block both the epithelial and nonepithelial actions of ... ,2020年7月1日 — The two commonly used mineralocorticoid receptor antagonists are spironolactone and eplerenone, although these agents are currently not ... ,Canrenoic acid (as the salt potassium canrenoate) is an aldosterone antagonist. Like spironolactone, it is a prodrug, which is metabolized to canrenone in the ... ,2012年11月22日 — Mineralocorticoid receptor (MR) antagonists are considered to be potassium-sparing diuretics that exert their effect by blocking MR in the kidney. ,Abstract. The first mineralocorticoid receptor (MR) antagonist, spironolactone, was developed almost 60 years ago to treat primary aldosteronism and pathological ... ,... 醛固酮拮抗劑"(aldosterone antagonist)、醛固酮受體拮抗劑、醛甾酮拮抗劑)是指一種利尿劑能拮抗在鹽皮質激素受體(Mineralocorticoid receptor)的醛固酮作用。 ,(mineralocorticoid receptor antagonist,. MRA)，由於不具選擇性，除了抑制. 醛固酮之外，同時也抑制了男性激素. (androgen)、黃體激素(progesterone)、.
| 相關軟體 FeedDemon 資訊 | |
|---|---|
 mr antagonist 相關參考資料
Antimineralocorticoid - Wikipedia
An antimineralocorticoid, also known as a mineralocorticoid receptor antagonist (MCRA) or aldosterone antagonist, is a diuretic drug which antagonizes the ... https://en.wikipedia.org Mineralocorticoid Antagonist - an overview | ScienceDirect ...
Two mineralocorticoid receptor antagonists, spironolactone and eplerenone, are currently approved by the FDA. Several non-steroid based ligands are in ... https://www.sciencedirect.com Mineralocorticoid receptor antagonist spironolactone prevents ...
Mineralocorticoid receptor (MR) antagonist spironolactone (SPL) is an effective agent for prevention of cardiovascular injury. However, whether and how SPL ... https://pubmed.ncbi.nlm.nih.go Mineralocorticoid Receptor Antagonists for Treatment of ...
Spironolactone and eplerenone are both mineralocorticoid-receptor antagonists. These compounds block both the epithelial and nonepithelial actions of ... https://www.ncbi.nlm.nih.gov Mineralocorticoid Receptor Antagonists in ESKD | American ...
2020年7月1日 — The two commonly used mineralocorticoid receptor antagonists are spironolactone and eplerenone, although these agents are currently not ... https://cjasn.asnjournals.org Mineralocorticoid Receptor Antagonists | DrugBank Online
Canrenoic acid (as the salt potassium canrenoate) is an aldosterone antagonist. Like spironolactone, it is a prodrug, which is metabolized to canrenone in the ... https://go.drugbank.com Mineralocorticoid receptor antagonists: their use and ... - Nature
2012年11月22日 — Mineralocorticoid receptor (MR) antagonists are considered to be potassium-sparing diuretics that exert their effect by blocking MR in the kidney. https://www.nature.com Third Generation Mineralocorticoid Receptor Antagonists ...
Abstract. The first mineralocorticoid receptor (MR) antagonist, spironolactone, was developed almost 60 years ago to treat primary aldosteronism and pathological ... https://www.ncbi.nlm.nih.gov 抗鹽皮質激素- 維基百科，自由的百科全書 - Wikipedia
... 醛固酮拮抗劑"(aldosterone antagonist)、醛固酮受體拮抗劑、醛甾酮拮抗劑)是指一種利尿劑能拮抗在鹽皮質激素受體(Mineralocorticoid receptor)的醛固酮作用。 https://zh.wikipedia.org 臺中榮總藥訊 - 台中榮總
(mineralocorticoid receptor antagonist,. MRA)，由於不具選擇性，除了抑制. 醛固酮之外，同時也抑制了男性激素. (androgen)、黃體激素(progesterone)、. http://www.vghtc.gov.tw |